ESTEVE CDMO expands U.S. capacity with additional $17.5 million investment in Morton Grove
ESTEVE CDMO, a global pure-play CDMO specializing in the development and manufacture of small-molecule APIs and pharmaceutical intermediates, has approved an additional $17.5 million capacity expansion and containment capabilities at…